Will Plavix be the next drug up for a genetic test? There are not many alternative drugs either that could easily replace the functionality of Plavix, it is a blood thinner. One idea would be to monitor patients with poor liver or kidney metabolization. as suggested here , a blog written...
Posted to
The Medical Quack .... by Barbara Duck
on 01-02-2009
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, Physician, personalized medicine, DNA, Genomics, healthcare, Health IT, Cardiology, Biotech, FDA, Information Overload, Pharmacogenomics, Sequencing, FDA warnings, Plavix
More marketing and potential hidden information seems to be making it's way to front, and interesting now on who wants to be reimbursed, insurance companies among the group. This appears to be an all out battle ground here. Weight gain and diabetes as side effects? Class action...
Cerner president speaks out about the insurance business, "they need to be redefined". Amgen CEO and President Kevin Sharer called for a better structured FDA . Overall the summary statement says the same thing I have brought up time and time again, who's going to to...
Posted to
The Medical Quack .... by Barbara Duck
on 08-31-2008
Filed under: Medically Related, Insurance, Pharma/FDA News, Other Items of Interest, medicare, health insurance, FDA, Cerner, Amgen, Fixiing Healthcare
More additional affiliations for the FDA to gather information. In the news recently have been other agreements with companies such as Blue Cross and others who will be providing data to also study the effects of drugs through medical record information in their files, based on claims, etc. No...
Posted to
The Medical Quack .... by Barbara Duck
on 08-18-2008
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, health insurance, healthcare IT, Pharma, Biotech, FDA, Medco, Pharmacogonomics
The most amazing part of this article is the cost compared to OxyContin, that was an eye opener for me, not being acquainted with pain killing medications. Xanax and Valium do not mix here either and we all remember the Anna Nicole Smith death, which probably accounted for bring methadone to the...
American Society of Clinical Oncology and Blue Cross/Blue Shield of Michigan will collect cancer information from 11 oncology practices in Michigan. Each physician will be paid around $3000.00 for their time in for the collection process. This is good for the exchange of information...
Posted to
The Medical Quack .... by Barbara Duck
on 08-12-2008
Filed under: Medically Related, Insurance, Pharma/FDA News, Cancer, FDA, Oncology, Blue Cross, American Society of Clinical Oncology, Heath Insurance
This is a big even in the move towards personalized medicine. This test will allow the physician to determine if the use of Herceptin is the right treatment for the patient with breast cancer! If it is determined not to work, then the patient is spared the expense and use of the drug, and...